000 05417nam a2200385 i 4500
999 _c393021
_d393021
001 393021
003 ES-MaUEC
005 20231215141453.0
006 a|||| o|||| 00| 0
007 cr nn 008mamaa
008 100301s2007 xxua o |||| 0|eng d
020 _a9781597452144
024 7 _a10.1385/1597452149
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC669.9
_b2007 EB
245 0 0 _aCardiovascular Proteomics :
_bMethods and Protocols
_cedited by Fernando Vivanco
250 _a1st edition 2007
264 1 _aTotowa, NJ
_bHumana Press
_c2007
300 _a1 recurso en línea (432 páginas)
_b134 ilustraciones, 6 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v357
505 0 _aAnalysis of the Heart Proteome -- Two-Dimensional Polyacrylamide Gel Electrophoresis for Cardiovascular Proteomics -- Analyzing the Cardiac Muscle Proteome by Liquid Chromatography-Mass Spectrometry-Based Expression Proteomics -- Two-Dimensional Differential Gel Electrophoresis of Rat Heart Proteins in Ischemia and Ischemia-Reperfusion -- Analysis of Antihypertensive Drugs in the Heart of Animal Models -- A Solubility Optimization Protocol for Two-Dimensional Gel Electrophoresis of Cardiac Tissue -- A Method for the Effective Depletion of Albumin From Cellular Extracts -- Heart Subproteomes -- Subcellular Fractionation -- Subfractionation of Heart Tissue -- Optimization of Cardiac Troponin I Pull-Down by Idm Affinity Beads and SELDI-TOF -- Proteomic Analysis of the Subunit Composition of Complex I (NADH:Ubiquinone Oxidoreductase) From Bovine Heart Mitochondria -- Identification of Targets of Phosphorylation in Heart Mitochondria -- Proteomics of Human Atheroma Plaques -- Characterization of the Human Atheroma Plaque Secretome by Proteomic Analysis -- Characterization of HSP27 Phosphorylation Sites in Human Atherosclerotic Plaque Secretome -- Western Array Analysis of Human Atherosclerotic Plaques -- The Proteome of Cells of the Cardiovascular System -- The Proteome of Endothelial Cells -- Proteomic Study of Caveolae and Rafts Isolated From Human Endothelial Cells -- Proteomic Identification of S-Nitrosylated Proteins in Endothelial Cells -- The Proteome and Secretome of Human Arterial Smooth Muscle Cell -- Real-Time In Vivo Proteomic Identification of Novel Kinase Substrates in Smooth Muscle -- Proteomic Analysis of Vascular Smooth Muscle Cells Treated With Ouabain -- Isolation and Culture of Adult Mouse Cardiac Myocytes -- Proteomic Analysis of Foam Cells -- Isolation of the Platelet Releasate -- Enrichment of Phosphotyrosine Proteome of Human Platelets by Immunoprecipitation -- Characterization of Circulating Human Monocytes by Proteomic Analysis -- Cardiovascular Biomarkers in Plasma -- Cardiovascular Biomarkers Discovery by SELDI-TOF Mass Spectrometry -- Detection of Biomarkers of Stroke Using SELDI-TOF -- Depletion of High-Abundance Proteins in Plasma by Immunoaffinity Substraction for Two-Dimensional Difference Gel Electrophoresis Analysis -- A Rapid, Economical, and Reproducible Method for Human Serum Delipidation and Albumin and IgG Removal for Proteomic Analysis -- Bioinformatics: Emerging Technologies -- Mitoproteome -- Techniques to Decipher Molecular Diversity by Phage Display.
520 _aOver the past few years, the power and potential of proteomics has become widely recognized. The use of proteomics for the study of complex diseases is increasing and is particularly applicable to cardiovascular disease, the leading cause of death in developed countries. The ability to investigate the complete proteome provides a critical tool toward elucidating the complex and multif- torial basis of cardiovascular biology, especially disease processes. Proteomics involves the integration of a number of technologies with the aim of analyzing all the proteins expressed by a biological system in response to various stimuli under different pathophysiological conditions. The proteomic approach offers the ability to evaluate simultaneously the changes in protein expression and cell signaling pathways in response to such conditions as atherosclerosis, c- diac hypertrophy, stroke, or heart failure. Cardiovascular Proteomics: Methods and Protocols covers many of the above aspects of the proteomic approach in the cardiovascular field. This v- ume takes the reader through the complete process of proteomic analysis, from the obtention of specific heart proteins (troponin I) to the new techniques of identifying risk biomarkers of atherome plaque rupture, analyzing the secretome of explanted endarterectomies cultured in vitro, or the application of phage display techniques to decipher the molecular diversity of blood vessels.
988 _aSpringer_Protocols_2007
650 7 _2embne
_9169062
_aAparato circulatorio
_xEnfermedades
_xAspectos moleculares
776 0 8 _iPrinted edition:
_z9781617376276
776 0 8 _iPrinted edition:
_z9781588295354
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1385/1597452149
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b12/2023
_dz
_eb
_zSI